Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combining drugs to optimize the therapy of hypertension: experimental evidence derived from animal models.

Literature DB >> 25832919

Combining drugs to optimize the therapy of hypertension: experimental evidence derived from animal models.

Danielle A Guimaraes¹, Jose E Tanus-Santos¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2015 PMID： 25832919 DOI： 10.1038/hr.2015.52

Source DB: PubMed Journal: Hypertens Res ISSN： 0916-9636 Impact factor: 3.872

Keyword Cloud
References

× No keyword cloud information.

11 in total

1. Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension.

Authors: Marcelo F Montenegro; Lucas C Pinheiro; Jefferson H Amaral; Diogo M O Marçal; Ana C T Palei; Antonio J Costa-Filho; Jose E Tanus-Santos
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2012-01-20 Impact factor: 3.000

2. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.

Authors: Alan H Gradman; Roland E Schmieder; Robert L Lins; Juerg Nussberger; Yanntong Chiang; Martin P Bedigian
Journal: Circulation Date: 2005-02-21 Impact factor: 29.690

3. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.

Authors: Carla S Ceron; Elen Rizzi; Danielle A Guimaraes; Alisson Martins-Oliveira; Stefany B Cau; Junia Ramos; Raquel F Gerlach; Jose E Tanus-Santos
Journal: Matrix Biol Date: 2012-02-10 Impact factor: 11.583

4. Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model.

Authors: Renata V Tiradentes; Cintia H Santuzzi; Erick Rg Claudio; Vinicius Mengal; Nyam F Silva; Henrique A F Neto; Nazaré S Bissoli; Glaucia R Abreu; Sonia A Gouvea
Journal: Hypertens Res Date: 2015-03-05 Impact factor: 3.872

Review 5. The role of direct renin inhibition in clinical practice: focus on combination therapy.

Authors: Haroon-Ur Rashid; Christian Mende
Journal: Am J Cardiovasc Drugs Date: 2011-10-01 Impact factor: 3.571

6. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.

Authors: Alisson Martins-Oliveira; Michele M Castro; Diogo M M Oliveira; Elen Rizzi; Carla S Ceron; Danielle Guimaraes; Rosana I Reis; Claudio M Costa-Neto; Dulce E Casarini; Amanda A Ribeiro; Raquel F Gerlach; Jose E Tanus-Santos
Journal: Int J Cardiol Date: 2012-04-06 Impact factor: 4.164

Combining drugs to optimize the therapy of hypertension: experimental evidence derived from animal models.

1. Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension.

2. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.

3. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.

4. Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model.

Review 5. The role of direct renin inhibition in clinical practice: focus on combination therapy.

6. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.

Review 7. The sympathetic nervous system as a target for the treatment of hypertension and cardiometabolic diseases.

8. Aliskiren vs. other antihypertensive drugs in the treatment of hypertension: a meta-analysis.

Review 9. Inducible nitric oxide synthase as a possible target in hypertension.

10. Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia.